Results

Total Results: 316 records

Showing results for "vascular".

241. Evidence Summary: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
     June 21, 2022 - Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial … Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of

242. C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/khUSqr94jqWPErt9ZRnQ95
     October 01, 2009 - Is C-reactive protein specific for vascular disease in women? Ann Intern Med. 2002;136:529-33. … Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

243. Ad-Br2Otj67Fendhhkltpa (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/aD-Br2oTJ67FeNdHHkLtPA
     April 22, 2004 - for pregnant women Kidney disease Chronic obstructive airways disease Heart disease, stroke, vascular

244. Decision Analysis: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/decision-analysis-for-aspirin/aspirin-to-prevent-cardiovascular-disease-and-cancer
     April 11, 2016 - Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual … for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular

245. Archived: Evidence Summary: Aspirin: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication
     March 15, 2007 - stroke did not differ between aspirin and placebo, 3 , 57  in healthy patients, 45  in patients with vascular … Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses

246. Archived: Decision Analysis: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/decision-analysis-for-aspirin/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     April 11, 2016 - Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual … for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular

247. Archived: Evidence Summary: Aspirin: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
     March 15, 2007 - stroke did not differ between aspirin and placebo, 3 , 57  in healthy patients, 45  in patients with vascular … Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses

248. T6Tquunynv3Twm65Bfash2 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/T6Tquunynv3tWM65BFash2
     October 01, 2015 - the FDA issued a safety communication indicat- ing a nonsignificant increase in major adverse cardio- vascular … in 2014 (35), a meta-analysis of 18 studies (n = 9072) showed no significant increase in all cardio- vascular

249. Archived: High Blood Cholesterol and Other Lipid Abnormalities: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/high-cholesterol-other-lipid-abnormalities-screening-1996
     January 01, 1996 - These benefits are now well established for persons with preexisting atherosclerotic vascular disease … Hypertriglycerid[a]emia and vascular risk. Lancet . 1993;342:781–787. [ PubMed ] 46.

250. Screening for Atrial Fibrillation With Electrocardiography: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/BtcFo6AtmQTWLeVDr55G39
     August 22, 2017 - hypertension, age "75 years [doubled], diabetes, stroke/transient ischemic attack/thromboembolism [doubled], vascular

251. 6Jfgjyjsbmc48Mj2Uksahb (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6jFgJYJSbMc48mj2uKsAhB
     October 01, 2014 - USPSTF recommends offering or referring adults who are overweight or obese and have additional cardio- vascular

252. Archived: Exercise Tolerance Testing to Screen for Coronary Heart Disease: A Systematic Review: Coronary Heart Disease (Electrocardiography): Screening (2004) | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/exercise-tolerance-testing-to-screen-for-coronary-heart-dise/coronary-heart-disease-electrocardiography-screening-2004
     February 03, 2004 - Arm exercise testing with myocardial scintigraphy in asymptomatic patients with peripheral vascular disease … Mean age ±SD, 46 ± 8 Age range: 37-59 y 69% men Known CAD, corticosteriods, collagen vascular

253. Postmenopausal Hormone Replacement Therapy for the Primary Prevention of Chronic Conditions: A Summary of the Evidence for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/sQ7hREGwnBm8Wh-LEFWP4F
     October 01, 2002 - Therapy 2 Postmenopausal Hormone Replacement Therapy 3 Reduction of coronary heart disease/cardio- vascular … Risk of vascular disease in women: smoking, oral contraceptives, noncontraceptive estrogens, and other

254. Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/umGzAGWUVDPcnmbdYnHf_a
     March 23, 2022 - interventions to prevent obesity-related morbidity and mortality,18 behavioral counseling to prevent cardio- vascular

255. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/v7w4xaGG822hVc_SCU3tQ_
     November 01, 2022 - that women in early menopause who are in good cardiovascular health and at low risk of adverse cardio- vascular

256. Recommendation: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication
     April 26, 2022 - Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual

257. Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for CVD Prevention in Adults Without Known CVD Risk Factors: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/HMSNGkJatRuN5VoVWfbuFL
     March 01, 2022 - Other Related USPSTF Recommendations The USPSTF has several recommendations for promoting cardio- vascular

258. Archived: Evidence Summary: Prostate Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary43/prostate-cancer-screening-2012
     October 07, 2011 - Medicare database study, perioperative rates of serious cardiovascular events were 3% and rates of vascular … studies ( n =1243 63 and 11,010 59 ), rates of cardiovascular events were 0.6% and 3% and rates of vascular

259. Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-TsBkyewVoFpC7htRmzWJa
     September 03, 2019 - treatment trials of women with noninva- sive and early stage breast cancer, such as fractures and cardio- vascular … Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics

260. Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/LPaUxRbrTshfsYVVTzenEQ
     April 26, 2022 - Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of